Zheng Quan Zhi Xing·2025-08-26 00:11Group 1: Zhaoyi Innovation - Zhaoyi Innovation reported good growth across all business lines in Q2 2024, with NOR Flash growing in the high single digits, niche DRAM up over 50%, MCU close to 20%, and sensor chips growing about 10% [1] - The company expects a quarter-on-quarter growth in Q3, with annual demand increasing and a tight supply for niche DRAM expected to last throughout the year [1] - The overall gross margin remains stable, with a moderate price increase anticipated for Flash and an improvement in DRAM gross margins [1] Group 2: Baillie Gifford - Baillie Gifford is collaborating with BMS to develop iza-bren and has initiated three key overseas clinical trials for treating triple-negative breast cancer, EGFR-mutant non-small cell lung cancer, and urothelial carcinoma [2] - The company has made breakthroughs in its RC nuclear drug platform, with the first candidate drug BL-RC001 submitted for domestic IND application [2] - Baillie Gifford aims to become a leading entry-level MNC in oncology treatment within five years [2] Group 3: Silicon Treasure Technology - Silicon Treasure Technology achieved significant growth in H1 2025, with revenue reaching 1.707 billion yuan, a year-on-year increase of 47.36%, and net profit up 51.56% [3] - The company’s construction and industrial adhesives performed well, with growth driven by brand advantages and technological innovation [3] - The company is expanding its production capacity and diversifying into organic silicon materials, adhesives, and lithium battery materials [3] Group 4: Tianyu Co., Ltd. - Tianyu Co., Ltd. reported an increase in gross margins across all business segments due to economies of scale and cost reduction [4] - The company has a rich pipeline of non-sartan products and plans to launch new varieties in the next two years [4] - The CDMO business grew by 44.33%, and the company is becoming a strategic supplier for multiple original research clients [4] Group 5: Lianying Laser - Lianying Laser achieved revenue of 1.533 billion yuan in H1 2025, a year-on-year increase of 5.3%, with net profit rising by 13.16% [5] - The company signed new orders worth 2.5 billion yuan, with significant contributions from lithium battery and non-lithium battery businesses [5] - Lianying Laser is expanding its presence in various sectors, including semiconductors, photovoltaics, and medical devices [5]